CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-09 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −17,692 | $32.47 | $574K | 232,550 |
| 2021-07-09 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −17,692 | 0 | ||
| 2021-07-09 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −26,705 | 115,123 | ||
| 2021-07-09 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −5,603 | 109,520 | ||
| 2021-07-07 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +30,424 | $26.49 | $806K | 262,974 |
| 2021-07-07 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −30,424 | $32.29 | $982K | 232,550 |
| 2021-07-07 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +1,884 | $26.49 | $50K | 234,434 |
| 2021-07-07 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −1,884 | $31.99 | $60K | 232,550 |
| 2021-07-07 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −1,884 | 0 | ||
| 2021-07-07 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,424 | 141,828 | ||
| 2021-06-28 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +3,973 | $26.49 | $105K | 236,523 |
| 2021-06-28 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −3,973 | $32.43 | $129K | 232,550 |
| 2021-06-28 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +1,891 | $26.49 | $50K | 234,441 |
| 2021-06-28 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −1,891 | $32.23 | $61K | 232,550 |
| 2021-06-28 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +948 | $19.47 | $18K | 233,498 |
| 2021-06-28 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −948 | $32.49 | $31K | 232,550 |
| 2021-06-28 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −1,891 | 1,884 | ||
| 2021-06-28 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −948 | 17,692 | ||
| 2021-06-28 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −3,973 | 172,252 | ||
| 2021-06-25 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +21,360 | $19.47 | $416K | 287,282 |
Page 26 of 35 · 689 trades